Filing Details

Accession Number:
0000878088-11-000078
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-19 14:42:00
Reporting Period:
2011-12-15
Filing Date:
2011-12-19
Accepted Time:
2011-12-19 14:42:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
878088 Par Pharmaceutical Companies Inc. PRX Pharmaceutical Preparations (2834) 223122182
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189790 M Ronald Nordmann C/O Par Pharmaceutical Companies Inc.
300 Tice Blvd.
Woodcliff Lake NJ 07677
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-12-15 2,500 $29.90 6,500 No 4 M Direct
Common Stock Disposition 2011-12-15 200 $32.50 6,300 No 4 S Direct
Common Stock Disposition 2011-12-15 2,200 $32.50 4,100 No 4 S Direct
Common Stock Disposition 2011-12-15 100 $32.50 4,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock, Option to buy Disposition 2011-12-15 2,500 $0.00 2,500 $29.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2003-01-08 2012-01-07 No 4 M Direct
Footnotes
  1. Mr. Nordmann was granted an option to purchase 2,500 shares of Common Stock under the Company's 1997 Directors Stock and Deferred Fee Plan on January 8, 2002, all of which vested on January 8, 2003. The expiration date of this option is January 7, 2012.